Literature DB >> 31311489

Cannabis Use in Adolescence: A Review of Neuroimaging Findings.

Yann Chye1, Erynn Christensen1, Murat Yücel1.   

Abstract

Objective: Shifting policies and widespread acceptance of cannabis for medical and/or recreational purposes have fueled worries of increased cannabis initiation and use in adolescents. In particular, the adolescent period is thought to be associated with an increased susceptibility to the potential harms of repeated cannabis use, due to being a critical period for neuromaturational events in the brain. This review investigates the neuroimaging evidence of brain harms attributable to adolescent cannabis use.
Methods: PubMed and Scopus searches were conducted for empirical articles that examined neuroimaging effects in both adolescent cannabis users and adult user studies that explored the effect of age at cannabis use onset on the brain.
Results: We found 43 studies that examined brain effect (structural and functional magnetic resonance imaging) in adolescent cannabis users and 20 that examined the link between onset age of cannabis use and brain effects in adult users. Studies on adolescent cannabis users relative to nonusers mainly implicate frontal and parietal regions and associated brain activation in relation to inhibitory control, reward, and memory. However, studies in adults are more mixed, many of which did not observe an effect of onset age of cannabis use on brain imaging metrics. Conclusions: While there is some evidence of compromised frontoparietal structure and function in adolescent cannabis use, it remains unclear whether the observed effects are specifically attributable to adolescent onset of use or general cannabis use-related factors such as depressive symptoms. The relative contribution of adolescent onset of cannabis use and use chronicity will have to be more comprehensively examined in prospective, longitudinal studies with more rigorous measures of cannabis use (dosage, exposure, dependence, constituent compounds such as the relative cannabinoid levels).

Entities:  

Keywords:  Cannabis; MRI; addiction; adolescence; neuroimaging; substance use disorder

Mesh:

Year:  2019        PMID: 31311489     DOI: 10.1080/15504263.2019.1636171

Source DB:  PubMed          Journal:  J Dual Diagn        ISSN: 1550-4271


  11 in total

Review 1.  Cannabis use and cannabis use disorder.

Authors:  Jason P Connor; Daniel Stjepanović; Bernard Le Foll; Eva Hoch; Alan J Budney; Wayne D Hall
Journal:  Nat Rev Dis Primers       Date:  2021-02-25       Impact factor: 52.329

2.  Dose mediates the protracted effects of adolescent THC exposure on reward and stress reactivity in males relevant to perturbation of the basolateral amygdala transcriptome.

Authors:  Jacqueline-Marie N Ferland; Randall J Ellis; Gregory Rompala; Joseph A Landry; James E Callens; Annie Ly; Micah D Frier; Teddy O Uzamere; Yasmin L Hurd
Journal:  Mol Psychiatry       Date:  2022-03-02       Impact factor: 15.992

3.  The Neurocognitive Effects of Cannabis Across the Lifespan.

Authors:  Jarrod M Ellingson; Jesse D Hinckley; J Megan Ross; Joseph P Schacht; L Cinnamon Bidwell; Angela D Bryan; Christian J Hopfer; Paula Riggs; Kent E Hutchison
Journal:  Curr Behav Neurosci Rep       Date:  2021-11-15

4.  Developmental trajectories of Big Five personality traits among adolescents and young adults: Differences by sex, alcohol use, and marijuana use.

Authors:  Scott A Jones; Ryan P Van Fossen; Wesley K Thompson; Fiona C Baker; Duncan B Clark; Bonnie J Nagel
Journal:  J Pers       Date:  2022-01-11

5.  Risks versus consequences of adolescent and young adult substance use: A focus on executive control.

Authors:  Monica Luciana
Journal:  Curr Addict Rep       Date:  2020-11-12

6.  Association between age of cannabis initiation and gray matter covariance networks in recent onset psychosis.

Authors:  Nora Penzel; Linda A Antonucci; Linda T Betz; Rachele Sanfelici; Johanna Weiske; Oliver Pogarell; Paul Cumming; Boris B Quednow; Oliver Howes; Peter Falkai; Rachel Upthegrove; Alessandro Bertolino; Stefan Borgwardt; Paolo Brambilla; Rebekka Lencer; Eva Meisenzahl; Marlene Rosen; Theresa Haidl; Lana Kambeitz-Ilankovic; Stephan Ruhrmann; Raimo R K Salokangas; Christos Pantelis; Stephen J Wood; Nikolaos Koutsouleris; Joseph Kambeitz
Journal:  Neuropsychopharmacology       Date:  2021-03-03       Impact factor: 7.853

7.  Bayesian causal network modeling suggests adolescent cannabis use accelerates prefrontal cortical thinning.

Authors:  Max M Owens; Matthew D Albaugh; Nicholas Allgaier; Dekang Yuan; Gabriel Robert; Renata B Cupertino; Philip A Spechler; Anthony Juliano; Sage Hahn; Tobias Banaschewski; Arun L W Bokde; Sylvane Desrivières; Herta Flor; Antoine Grigis; Penny Gowland; Andreas Heinz; Rüdiger Brühl; Jean-Luc Martinot; Marie-Laure Paillère Martinot; Eric Artiges; Frauke Nees; Dimitri Papadopoulos Orfanos; Herve Lemaitre; Tomáš Paus; Luise Poustka; Sabina Millenet; Juliane H Fröhner; Michael N Smolka; Henrik Walter; Robert Whelan; Scott Mackey; Gunter Schumann; Hugh Garavan
Journal:  Transl Psychiatry       Date:  2022-05-06       Impact factor: 7.989

Review 8.  Alcohol and Cannabis Use and the Developing Brain.

Authors:  Briana Lees; Jennifer Debenham; Lindsay M Squeglia
Journal:  Alcohol Res       Date:  2021-09-09

9.  Age- and Sex-Related Cortical Gray Matter Volume Differences in Adolescent Cannabis Users: A Systematic Review and Meta-Analysis of Voxel-Based Morphometry Studies.

Authors:  Aliyah Allick; Grace Park; Kwon Kim; Michelle Vintimilla; Krutika Rathod; Rachael Lebo; Julie Nanavati; Christopher J Hammond
Journal:  Front Psychiatry       Date:  2021-12-01       Impact factor: 4.157

10.  Association of Cannabis Use During Adolescence With Neurodevelopment.

Authors:  Matthew D Albaugh; Jonatan Ottino-Gonzalez; Amanda Sidwell; Claude Lepage; Anthony Juliano; Max M Owens; Bader Chaarani; Philip Spechler; Nicholas Fontaine; Pierre Rioux; Lindsay Lewis; Seun Jeon; Alan Evans; Deepak D'Souza; Rajiv Radhakrishnan; Tobias Banaschewski; Arun L W Bokde; Erin Burke Quinlan; Patricia Conrod; Sylvane Desrivières; Herta Flor; Antoine Grigis; Penny Gowland; Andreas Heinz; Bernd Ittermann; Jean-Luc Martinot; Marie-Laure Paillère Martinot; Frauke Nees; Dimitri Papadopoulos Orfanos; Tomáš Paus; Luise Poustka; Sabina Millenet; Juliane H Fröhner; Michael N Smolka; Henrik Walter; Robert Whelan; Gunter Schumann; Alexandra Potter; Hugh Garavan
Journal:  JAMA Psychiatry       Date:  2021-06-16       Impact factor: 25.911

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.